Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 22, 2013, Pages 8954-8959

  Hughes, Bridget T ^a   Sidorova, Julia ^b   Swanger, Jherek ^a   Monnat, Raymond J ^b   Clurman, Bruce E ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclin A; Wee1

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E;

ALLELE; ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DNA REPLICATION; ENZYME PHOSPHORYLATION; GENE MUTATION; GENE TARGETING; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 84878460802     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1302927110     Document Type: Article

References (49)

1. Morgan DO (1995) Principles of CDK regulation. Nature 374(6518):131-134.
2. Atherton-Fessler S, Hannig G, Piwnica-Worms H (1993) Reversible tyrosine phosphorylation and cell cycle control. Semin Cell Biol 4(6):433-442.
3. Berry LD, Gould KL (1996) Regulation of Cdc2 activity by phosphorylation at T14/Y15. Prog Cell Cycle Res 2:99-105.
4. Coleman TR, Dunphy WG (1994) Cdc2 regulatory factors. Curr Opin Cell Biol 6(6): 877-882.
5. Ferrell JE, Jr., et al. (2009) Simple, realistic models of complex biological processes: Positive feedback and bistability in a cell fate switch and a cell cycle oscillator. FEBS Lett 583(24):3999-4005.
6. Bartek J, Lukas J (2007) DNA damage checkpoints: From initiation to recovery or adaptation. Curr Opin Cell Biol 19(2):238-245.
7. Sørensen CS, Syljuåsen RG (2012) Safeguarding genome integrity: The checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Res 40(2):477-486.
8. Hwang HC, Clurman BE (2005) Cyclin E in normal and neoplastic cell cycles. Oncogene 24(17):2776-2786.
9. Sherr CJ (1993) Mammalian G1 cyclins. Cell 73(6):1059-1065.
10. Chow JP, et al. (2003) Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints. J Biol Chem 278(42):40815-40828.
11. Gabrielli BG, Lee MS, Walker DH, Piwnica-Worms H, Maller JL (1992) Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex. J Biol Chem 267(25):18040-18046.
12. Gu Y, Rosenblatt J, Morgan DO (1992) Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 11(11):3995-4005.
13. Kiyokawa H, Ray D (2008) In vivo roles of CDC25 phosphatases: Biological insight into the anti-cancer therapeutic targets. Anticancer Agents Med Chem 8(8):832-836.
14. Beck H, et al. (2010) Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase. J Cell Biol 188(5):629-638.
15. Beck H, et al. (2012) Cyclin-dependent kinase suppression by WEE1 kinase protects the genome through control of replication initiation and nucleotide consumption. Mol Cell Biol 32(20):4226-4236.
16. Domínguez-Kelly R, et al. (2011) Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease. J Cell Biol 194(4):567-579.
17. Falck J, Mailand N, Syljuåsen RG, Bartek J, Lukas J (2001) The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410(6830): 842-847.
18. Zhao H, Chen X, Gurian-West M, Roberts JM (2012) Loss of cyclin-dependent kinase 2 (CDK2) inhibitory phosphorylation in a CDK2AF knock-in mouse causes misregulation of DNA replication and centrosome duplication. Mol Cell Biol 32(8):1421-1432.
19. Strohmaier H, et al. (2001) Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413(6853):316-322.
20. Koepp DM, et al. (2001) Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294(5540):173-177.
21. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK (2001) Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413(6853):311-316.
22. Ekholm-Reed S, et al. (2004) Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Cancer Res 64(3):795-800.
23. Loeb KR, et al. (2005) A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 8(1):35-47.
24. Minella AC, et al. (2002) p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol 12(21):1817-1827.
25. Minella AC, et al. (2008) Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev 22(12):1677-1689.
26. Spruck CH, Won KA, Reed SI (1999) Deregulated cyclin E induces chromosome instability. Nature 401(6750):297-300.
27. Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM (1996) Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 10(16):1979-1990.
28. Won KA, Reed SI (1996) Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J 15(16): 4182-4193.
29. Grim JE, et al. (2008) Isoform-and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol 181(6):913-920.
30. Russell DW, Hirata RK (1998) Human gene targeting by viral vectors. Nat Genet 18(4): 325-330.
31. Bartek J, Lukas C, Lukas J (2004) Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 5(10):792-804.
32. Donzelli M, Draetta GF (2003) Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 4(7):671-677.
33. Hoffmann I, Draetta G, Karsenti E (1994) Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J 13(18):4302-4310.
34. Li C, Andrake M, Dunbrack R, Enders GH (2010) A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export. Mol Cell Biol 30(1):116-130.
35. Minella AC, Grim JE, Welcker M, Clurman BE (2007) p53 and SCF(Fbw7) cooperatively restrain cyclin E-associated genome instability. Oncogene 26(48):6948-6953.
36. Rajagopalan H, et al. (2004) Inactivation of hCDC4 can cause chromosomal instability. Nature 428(6978):77-81.
37. Sidorova JM, Li N, Schwartz DC, Folch A, Monnat RJ, Jr. (2009) Microfluidic-assisted analysis of replicating DNA molecules. Nat Protoc 4(6):849-861.
38. Sidorova JM, Kehrli K, Mao F, Monnat R, Jr. (2013) Distinct functions of human RECQ helicases WRN and BLM in replication fork recovery and progression after hydroxyurea-induced stalling. DNA Repair (Amst) 12(2):128-139.
39. Sabatinos SA, Green MD, Forsburg SL (2012) Continued DNA synthesis in replication checkpoint mutants leads to fork collapse. Mol Cell Biol 32(24):4986-4997.
40. Poli J, et al. (2012) dNTP pools determine fork progression and origin usage under replication stress. EMBO J 31(4):883-894.
41. Boutros R, Dozier C, Ducommun B (2006) The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 18(2):185-191.
42. Sørensen CS, et al. (2003) Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3(3):247-258.
43. Gagou ME, Zuazua-Villar P, Meuth M (2010) Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1. Mol Biol Cell 21(5): 739-752.
44. Boutros R, Lobjois V, Ducommun B (2007) CDC25 phosphatases in cancer cells: Key players? Good targets? Nat Rev Cancer 7(7):495-507.
45. Stathis A, Oza A (2010) Targeting Wee1-like protein kinase to treat cancer. Drug News Perspect 23(7):425-429.
46. Galaktionov K, et al. (1995) CDC25 phosphatases as potential human oncogenes. Science 269(5230):1575-1577.
47. Ray D, Kiyokawa H (2008) CDC25A phosphatase: A rate-limiting oncogene that determines genomic stability. Cancer Res 68(5):1251-1253.
48. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O (2009) Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4(12):1798-1806.
49. Herschleb J, Ananiev G, Schwartz DC (2007) Pulsed-field gel electrophoresis. Nat Protoc 2(3):677-684.